Jacob Ballas makes modest returns from Vivimed Labs’ part-exit

By Ranjani Raghavan

  • 03 Oct 2016
Premium

Mid-market private equity firm Jacob Ballas Capital has marked its third liquidity event this year as it looks to harvest its investments from its last India-focused funds raised almost a decade ago.The firm has part-exited active pharmaceutical ingredients (API) and chemicals maker Vivimed Labs Ltd last week, its second such ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.